ロード中...
Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis
INTRODUCTION: Interventional ICU trials have followed up patients for variable duration. However, the optimal duration of follow-up for the determination of mortality endpoint in such trials is uncertain. We aimed to determine the most logical and practical mortality end-point in clinical trials of...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2750185/ https://ncbi.nlm.nih.gov/pubmed/19653888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc7988 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|